AstraZeneca Says Prilosec OTC Sales “Flattish” In The First Quarter
This article was originally published in The Tan Sheet
Executive Summary
Sales of Procter & Gamble's Prilosec OTC leveled off in the first quarter compared to the three months of its initial launch last year, according to AstraZeneca